Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2

Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis

Peter C. Maisonpierre, Chitra Suri, Pamela F. Jones et al. · Science · 1997 · 3.6K citations

Life Sciences, Developmental Biology, Molecular Biology +16

Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF

Jocelyn Holash, Peter C. Maisonpierre, Debra Compton et al. · Science · 1999 · 2.2K citations

Medicine, Cancer Biology, Oncology +17

Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning

Samuel Davis, Thomas H. Aldrich, Pamela F. Jones et al. · Cell · 1996 · 2K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Angiopoietin-1 protects the adult vasculature against plasma leakage

Gavin Thurston, John S. Rudge, Ella Ioffe et al. · Nature Medicine · 2000 · 1.3K citations

Medicine, Hematology, Immunology +13

Intratumor microvessel density as a prognostic factor in cancer.

Noel Weidner · PubMed · 1995 · 876 citations

Veterinary Medicine, Cancer Biology, Oncology +14